shafi_kai_bg

samfurori

Tofacitinib Intermediate (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] succinic acid da (3R, 4R) - N, 4-dimethyl-1- (phenylmethyl) -3-piperidine amine CAS No. 477600 -71-8

Takaitaccen Bayani:

Tsarin kwayoyin halitta:Saukewa: C48H62N4O8
Nauyin Kwayoyin Halitta:823.028


Cikakken Bayani

Tags samfurin

Bayani

Matsakaicin mu na tofacitinib yana da mahimmanci a cikin tsarin masana'anta na tofacitinib, sanannen magani da ake amfani da shi don magance wasu nau'ikan cututtukan fata.Wannan tsaka-tsakin yana taka muhimmiyar rawa wajen samar da tofacitinib, yana ba da gudummawa ga tasiri da ingancinsa.Via (2R,3R) -2,3-bis [(4-methylbenzoyl) oxy] succinic acid da (3R,4R) -N,4-dimethyl-1- (phenylmethyl) - Daidaitaccen haɗin 3-piperidinamines, mu Samfurin yana tabbatar da haɓakar tofacitinib mai inganci wanda ya dace kuma ya wuce matsayin masana'antu.

Tsarin kwayoyin halitta da nauyin mu na tofacitinib tsaka-tsakin yana nuna tsabta da ƙarfinsa, yana mai da shi abin dogara ga tsarin masana'antu na magunguna.Tare da kayan aikin da aka auna a hankali, wannan tsaka-tsakin yana tabbatar da daidaito da ingancin samfurin ƙarshe, tofacitinib.Kaddarorin kwayoyin sa kuma suna ba da gudummawa ga kwanciyar hankali na tofacitinib gabaɗaya da rayuwar shiryayye, yana tabbatar da ya kasance mai inganci kuma abin dogaro na dogon lokaci.

Zaba Mu

JDK ya mallaki wuraren samar da ajin farko da na'urorin sarrafa inganci, wanda ke tabbatar da tsayayyen samar da matsakaicin API.Ƙwararrun ƙungiyar sun tabbatar da R&D na samfurin.A kan duka biyun, muna neman CMO & CDMO a cikin gida da kasuwannin duniya.


  • Na baya:
  • Na gaba: